FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Warfarin Sodium from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Prosthetic Heart Valve
• Pulmonary Embolism
• Valvular Heart Disease
• Venous Thromboembolism

Drugs mentioned

• WARFARIN SODIUM (Warfarin sodium)

Snippet

SUPPL AP for WARFARIN SODIUM (WARFARIN SODIUM)